Neurocognition and psychopathology are robust predictors of community functioning and relapse/rehospitalization in @entity161 . Existing studies are however limited because they have ignored the most chronic, treatment-resistant @entity1 . Moreover, the prediction of functional outcomes has yet to be extended to the duration of community tenure, an indicator of the capacity of chronically-hospitalized @entity1 to gain traction in the community. The current study examined neurocognition and symptom severity at discharge as potential predictors of community tenure in chronically-hospitalized treatment-resistant @entity1 . The study recruited 90 @entity1 with treatment-resistant @entity161 who received services on an inpatient unit. @entity1 completed measures of psychopathology and neurocognition prior to discharge. Following discharge, @entity1 were tracked at current residences six months and one year post-discharge to assess community tenure. The percentage of individuals who continued to live in the community at 12-month follow-up was 51%. Severe negative symptoms but not @entity149 or positive symptoms was a significant predictor of shorter post-hospital community tenure. Of the negative symptoms domain, @entity4270 proved to be the most relevant predictor of community tenure in the sample. The capacity to elicit goal-directed behaviors in response to anticipated physical and social rewards may be an important treatment target for sustaining community tenure.

An examination of neurocognition and symptoms as predictors of post-hospital community tenure in treatment resistant XXXX .

@entity1 :: ('9606', 'Species') :: ['participants', 'patients', 'Participants', 'people'] @entity149 :: ('MESH:D002493', 'Disease') :: ['neurocognitive impairment'] @entity161 :: ('MESH:D012559', 'Disease') :: ['schizophrenia'] @entity4270 :: ('MESH:D059445', 'Disease') :: ['anhedonia-asociality']
@entity161 :: (MESH:D012559,Disease) :: ['schizophrenia']
